<DOC>
	<DOC>NCT01019785</DOC>
	<brief_summary>During IVF treatment women will be randomized into supplementation with a high or a low dose of Vitamin D Main outcome Laboratory pregnancy, live pregnancy at 12 weeks, Baby take home rate, OHSS Secondary outcome: 1. Pregnancy complications (pregnancy hypertension, SGA, Diabetes) 2.Thrombin generation</brief_summary>
	<brief_title>Vitamin D During In Vitro Fertilisation (IVF) - A Prospective Randomized Trial</brief_title>
	<detailed_description />
	<mesh_term>Pregnancy Complications</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<criteria>All women initiating IVF treatment Women that have entered the study before</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2009</verification_date>
	<keyword>Pregnancy rate (pos test, live fetus at 12 weeks, baby home)</keyword>
	<keyword>Pregnancy complication (Pregnancy hypertension, SGA, diab)</keyword>
	<keyword>Thrombin generation</keyword>
</DOC>